URSB Bancorp, Inc. financials

URSB CIK 0002084261

Source: EDGAR filings · Built 2026-08-18T00:19:49Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept Q2 2026Q1 2026Q1 2026Q2 2026Q1 2026
Free Cash Flow 1.27M 1.36M 387.00K 221.00K
Net Debt 40.03M 33.58M 45.18M
Return on Equity (ROE) 0.57% 0.39% 0.38% 0.71%
Return on Assets (ROA) 0.06% 0.04%
Debt-to-Equity 1.17× 1.30× 2.68×
Effective Tax Rate 17.88% 12.43% 8.97% 40.36%
Cash Conversion Ratio 5.98× 8.85× 5.62× 1.70×
Accruals Ratio -0.00× -0.00×
CapEx Coverage 18.69× 91.40× 33.25× 45.20×
Free Cash Flow Per Share $0.60 $0.63

Income Statement

Concept Q2 2026Q1 2026Q1 2026Q2 2026Q1 2026
Income Tax Expense (Benefit) 49.00K 22.00K 7.00K 90.00K
Net Income (Loss) Attributable to Parent 225.00K 155.00K 71.00K 133.00K
Earnings Per Share, Basic $0.11 $0.07
Weighted Average Number of Shares Outstanding, Basic 2.11M 2.15M
Earnings Per Share, Diluted $0.11 $0.07
Weighted Average Number of Shares Outstanding, Diluted 2.11M 2.15M

Balance Sheet

Concept Q2 2026Q1 2026Q1 2026Q2 2026Q1 2026
Cash and Cash Equivalents, at Carrying Value 6.04M 18.00M 8.39M
Assets 381.51M 380.61M 367.97M
Liabilities 341.97M 340.83M 347.98M
Stockholders' Equity Attributable to Parent 39.54M 39.78M 19.99M 18.79M 18.68M
Common Stock, Shares, Outstanding 2.33M

Cash Flow Statement

Concept Q2 2026Q1 2026Q1 2026Q2 2026Q1 2026
Net Cash Provided by (Used in) Operating Activities 1.35M 1.37M 399.00K 226.00K
Payments to Acquire Property, Plant, and Equipment 72.00K 15.00K 12.00K 5.00K
Net Cash Provided by (Used in) Investing Activities -16.43M -4.24M -11.15M -597.00K
Net Cash Provided by (Used in) Financing Activities 12.74M 12.47M 8.90M 1.53M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (URSB CIK 0002084261), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

AP

AMPCO-PITTSBURGH CORP

GRC

The Gorman-Rupp Company

PTPI

Petros Pharmaceuticals, Inc.